Literature DB >> 24248476

Evidence for modest familial co-aggregation between dementia and parkinsonism.

Adina L Feldman1, Karin Wirdefeldt, Anna L V Johansson, Margaret Gatz, Nancy L Pedersen.   

Abstract

To investigate the contribution of shared familial risk to the co-occurrence of dementia and parkinsonism by studying familial co-aggregation of Alzheimer's disease (AD) and Parkinson's disease (PD). Using Swedish population-based registers we constructed two cohorts; a first-degree relative cohort of persons born 1932-1960 (n = 2,775,332) and a spouse cohort of persons born 1890-1960 (n = 4,736,006). Study persons were followed up between 1969 and 2009 in the National Patient and Cause of Death Registers. We modeled the association between incidence of disease and having at least one affected relative using Cox proportional hazard regression that estimated hazard ratios (HRs) with 95% confidence intervals (CIs) adjusted for age, sex and number of relatives. Within each disorder; dementia, AD, parkinsonian disorders and PD, there was a strong association between risk of disease and having at least one affected sibling or parent. There was also a modest shared familial risk between the diseases; risk of parkinsonian disorders was associated with having a sibling with AD (HR 1.35, 95% CI 1.11-1.65) and risk of dementia was associated with having a sibling with PD (HR 1.20, 95% CI 1.02-1.41). There were no meaningful familial risks among spouses. The risk of co-occurring dementia in PD was considerably increased (HR 2.83, 95% CI 2.76-2.89). There is strong familial aggregation within dementia, AD, parkinsonian disorders and PD, and modest familial co-aggregation between dementia and parkinsonism. Thus, co-occurrence of dementia and parkinsonism is not primarily caused by shared familial risk between AD and PD.

Entities:  

Mesh:

Year:  2013        PMID: 24248476     DOI: 10.1007/s10654-013-9864-1

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

1.  Validity of family history data on PD: evidence for a family information bias.

Authors:  A Elbaz; S K McDonnell; D M Maraganore; K J Strain; D J Schaid; J H Bower; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

2.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease.

Authors:  S Costello; Y Bordelon; J Bronstein; B Ritz
Journal:  Eur J Neurol       Date:  2010-03-17       Impact factor: 6.089

3.  The Swedish Multi-generation Register.

Authors:  Anders Ekbom
Journal:  Methods Mol Biol       Date:  2011

4.  Familial aggregation of Parkinson's disease: a meta-analysis.

Authors:  Evan L Thacker; Alberto Ascherio
Journal:  Mov Disord       Date:  2008-06-15       Impact factor: 10.338

Review 5.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

6.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

7.  Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease.

Authors:  S F Mickel; S K Broste; B C Hiner
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

Review 8.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

9.  Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia.

Authors:  K Marder; M X Tang; B Alfaro; H Mejia; L Cote; E Louis; Y Stern; R Mayeux
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

10.  Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.

Authors:  Pravat K Mandal; Jay W Pettegrew; Eliezer Masliah; Ronald L Hamilton; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-09-01       Impact factor: 4.414

View more
  5 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease.

Authors:  Erica J Melief; Eiron Cudaback; Nikolas L Jorstad; Emily Sherfield; Nadia Postupna; Angela Wilson; Martin Darvas; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  J Neurosci Res       Date:  2015-03-30       Impact factor: 4.164

3.  Exploration of Cognitive Outcomes and Risk Factors for Cognitive Decline Shared by Couples.

Authors:  Hee Won Yang; Jong Bin Bae; Dae Jong Oh; Dong Gyu Moon; Eunji Lim; Jin Shin; Bong Jo Kim; Dong Woo Lee; Jeong Lan Kim; Jin Hyeong Jhoo; Joon Hyuk Park; Jung Jae Lee; Kyung Phil Kwak; Seok Bum Lee; Seok Woo Moon; Seung-Ho Ryu; Shin Gyeom Kim; Ji Won Han; Ki Woong Kim
Journal:  JAMA Netw Open       Date:  2021-12-01

4.  The Rotterdam Scan Study: design update 2016 and main findings.

Authors:  M Arfan Ikram; Aad van der Lugt; Wiro J Niessen; Peter J Koudstaal; Gabriel P Krestin; Albert Hofman; Daniel Bos; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-12-09       Impact factor: 8.082

5.  Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study.

Authors:  Chih-Hao Shen; Chung-Hsing Chou; Feng-Cheng Liu; Te-Yu Lin; Wen-Yen Huang; Yu-Chiao Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.